Interplay between the p53 tumor suppressor protein family and Cdk5: Novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors

By Schmid Gerald   Strosznajder Joanna   Węsierska-Gdek Józefa  

Molecular Neurobiology, Vol. 34, Iss. 1, 2006-08 ,pp. : 27-49

Humana Press, Inc

Access to resources Recommend Favorite

Several Noncontiguous Domains of CDK4 Are Involved in Binding to the P16 Tumor Suppressor Protein

By Ceha H.M.   Nasser I.   Medema R.H.   Slebos R.J.C.  

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 2, 1998-08 ,pp. : 550-555

Elsevier

Access to resources Recommend Favorite

Identification of Ribosomal Protein L34 as a Novel Cdk5 Inhibitor

By Moorthamer M.   Chaudhuri B.  

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 3, 1999-02 ,pp. : 631-638

Elsevier

Access to resources Recommend Favorite

Role of tumor suppressor p53 domains in selective binding to supercoiled DNA

By Jovin T.M.  

Nucleic Acids Research, Vol. 30, Iss. 22, 2002-11 ,pp. : 4966-4974

Oxford University Press

Access to resources Recommend Favorite

Discovery of novel tumor suppressor p53 response elements using information theory

By Lyakhov Ilya G.  

Nucleic Acids Research, Vol. 36, Iss. 11, 2008-06 ,pp. : 3828-3833

Oxford University Press

Access to resources Recommend Favorite